Frank H. Valone M.D. is Chief Medical Officer at FIBROGEN INC (FGEN). They have made 4 open-market trades across 1 company since 2015, most recently 2016-04-01.
CIK 0000921299
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 4 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| FGEN | 104,884 | $1.0M |
Shares reported on the most recent Form 4, priced at the 2016-04-04 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| FGEN | SELL | 2016-04-01 | 2016-04-04 | $21.10 | $450K | -2.4% | -20.7% | -21.2% |
| FGEN | SELL | 2016-03-01 | 2016-03-03 | $16.84 | $181K | -6.9% | +12.2% | +0.9% |
| FGEN | SELL | 2016-03-01 | 2016-03-03 | $16.84 | $362K | -6.9% | +12.2% | +0.9% |
| FGEN | SELL | 2016-02-16 | 2016-02-18 | $18.41 | $396K | -7.9% | -4.9% | -8.1% |
| FGEN | SELL · 10b5-1 | 2015-11-02 | 2015-11-04 | $23.18 | $232K | -21.7% | +2.4% | -38.0% |
| FGEN | SELL · 10b5-1 | 2015-10-19 | 2015-10-21 | $23.00 | $230K | -21.7% | +2.4% | -28.1% |
| FGEN | SELL · 10b5-1 | 2015-10-01 | 2015-10-02 | $21.38 | $214K | -21.7% | +2.4% | +2.4% |
| FGEN | SELL · 10b5-1 | 2015-09-01 | 2015-09-03 | $23.58 | $236K | -21.7% | +2.4% | +2.4% |
| FGEN | SELL · 10b5-1 | 2015-08-03 | 2015-08-05 | $23.37 | $234K | -21.7% | +2.4% | +2.4% |
| FGEN | SELL · 10b5-1 | 2015-07-20 | 2015-07-21 | $23.70 | $24K | -21.7% | +2.4% | +2.4% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.